Navigation Links
BioMed Central presents Challenges in Malaria Research: Progress Towards Elimination

In conjunction with its journals Malaria Journal and Parasites and Vectors, the open access publisher BioMed Central is proud to present its second malaria conference, "Challenges in Malaria Research: Progress towards elimination" at the University of Basel, Switzerland from 10-12 October 2012.

With steps being made towards better control of malaria, this conference focuses on the eventual goal of eradication. Although malaria elimination is currently a possibility in some regions, worldwide elimination is a much bigger challenge that will require further research and progress in many areas relevant to the transmission of the disease. Each of the 10 conference sessions will deal with different aspects of research for elimination with the aim of bringing different disciplines together to generate new tools and strategies for fighting malaria.

Keynote speakers include:

  • Pedro Alonso, Barcelona Centre for International Health Research (CRESIB), Spain
  • Simon Hay, University of Oxford, UK
  • Robert Newman, Global Malaria Programme WHO, Geneva, Switzerland
  • Nicholas J. White, University of Oxford, UK & Mahidol University, Thailand
  • Teun Bousema, London School of Hygiene & Tropical Medicine, UK
Professor Marcel Tanner from the Swiss Tropical & Public Health Institute, Basel, and co-chair of the conference Organizing Committee said "This meeting maintains the momentum towards malaria elimination/eradication through the presentation and discussion of innovative science to be applied in the different malaria endemic areas."

Contact: Rebecca Fairbairn
BioMed Central

Page: 1

Related medicine news :

1. LA BioMed investigator, Dr. Yutaka Niihara, developing novel cellular therapy
2. LA BioMed offers unique educational and research opportunity to local high school seniors
3. Louisiana Tech biomedical engineering professor earns recognition, funding for research
4. LA BioMed investigator Dr. Christina Wang spearheads study on new male contraceptive gel
5. LA BioMed investigators, Drs. Kevin Bruhn and Noah Craft, develop novel treatment for melanoma
6. UMMS researcher Victor Ambros, Ph.D., named co-recipient of 2012 Janssen Award for Biomedical Research
7. UCSC physicist Alexander Sher named Pew Scholar in the Biomedical Sciences
8. Applied nanobiomedicine: Exploiting nanoparticles to hunt for hidden cancer cells
9. LA BioMeds Dr. Patricia Dickson researching treatments for neurodegenerative disorders
10. LA BioMed receives Grand Challenges Explorations grant
11. Biomedical researchers receive Hartwell Foundation awards
Post Your Comments:
(Date:11/26/2015)... ... November 26, 2015 , ... ... for mental health and wellness consultation, has collaborated with Women’s Web – ... their reader’s queries on topics on mental and emotional well-being relationship, life ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... where preparing the perfect dish and pleasing the palates of attendees is of ... bringing a dish to a seasonal get-together, give these recipes a try this ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dr. John Pierce, Medical Director ... about hair loss treatment with the Capillus272™ Pro laser therapy cap. FDA cleared for ... and fuller hair, without the need for surgery, prescription pills, or topical foams. ...
(Date:11/25/2015)... ... November 25, 2015 , ... According to an article published November ... more widely heralded as a breakthrough for performing hernia repairs. The article explains that ... surgery is that it can greatly reduce the pain that a patient might otherwise ...
(Date:11/25/2015)... Raton, Florida (PRWEB) , ... November 25, 2015 ... ... diagnostic testing for physicians and athletic programs, launches new Wimbledon Athletics ... importance of testing young athletes for unsuspected cardiac abnormalities. About 2,000 people under ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015  Amgen (NASDAQ: ... License Application (BLA) with the United States ... ABP 501, a biosimilar candidate to Humira ® ... biosimilar application submitted to the FDA and represents Amgen,s ... Sean E. Harper , M.D., executive vice president ...
(Date:11/25/2015)... , Nov. 25, 2015  Linden Care, LLC, ... optimizing treatment outcomes for patients suffering from chronic pain, ... for a Temporary Restraining Order (TRO) enjoining Express Scripts ... two companies. --> --> ... all of its legal options. --> ...
(Date:11/25/2015)... 25, 2015 On Tuesday, November 24, ... trial against Wright Medical Technology, Inc. for product ... metal-on-metal hip implant device, awarded $11 million in ... week trial and three days of deliberations, the ... was defectively designed and unreasonably dangerous, and that ...
Breaking Medicine Technology: